← All trials
NCT04401384
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2020
- Primary completion
- Dec 31, 2020
- Completion date
- Jun 30, 2021
- First posted
- May 25, 2020
- Last posted
- May 25, 2020
- Enrollment
- 352
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Heilongjiang University of Traditional Chinese MedicineLead sponsor
- Harbin maternal and child health care hospitalCollaborator
- Hegang maternal and child health care hospitalCollaborator
- Jiamusi maternal and child health care hospitalCollaborator
- Jixi maternal and child health care hospitalCollaborator
- Mudanjiang maternal and child health care hospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.